Probiodrug's Series C Round

Probiodrug raised a round of funding on June 15, 2006.

Probiodrug is dedicated to the discovery and development of small molecule drugs against novel molecular targets for the treatment of neuronal- and inflammatory diseases. The company develops therapeu…

Articles about Probiodrug's Series C Round: